Dr. William Petty is a medical oncologist and hematologist in the department of Medical Oncology at the Wake Forest Medical Center and Wake Forest Comprehensive Cancer Center. As Director of the Thoracic Oncology program, he specializes in treating patients diagnosed with lung cancer and malignant pleural mesothelioma. Dr. Petty’s philosophy on taking care of patients
A group of researchers from cancer centers in Vienna has announced that they’ve identified a therapeutic target that, when inhibited, enhances mesothelioma tumors’ sensitivity to chemotherapy and radiotherapy. The group believes that this approach may yield a novel and effective treatment approach for the rare, asbestos-related disease.
Dr. Clarke is a medical oncologist within Duke Health and the Duke Cancer Institute in Durham, North Carolina. He specializes in treating patients with cancers of the chest, including malignant mesothelioma and lung cancer. He says that the most rewarding part of his work is developing long-term relationships with his patients and their families throughout
Dr. Tong is an accomplished clinical surgeon at Duke Health and Duke Cancer Institute in Durham, North Carolina. Her focus is on thoracic oncology and minimally invasive thoracic surgery and her clinical expertise is in lung and esophageal cancer surgery as well as surgery for the treatment of malignant pleural mesothelioma. She has achieved international
One of the most challenging aspects of pursuing a mesothelioma or asbestos-related lung cancer lawsuit is the significant gap between when the victim’s exposure took place and when their illness is diagnosed. It’s hard for anybody to remember details from four or five decades earlier, and this is especially true when fighting a fatal disease.
Dr. Abraham Chachoua is the Director of the Lung Cancer Center at the Perlmutter Cancer Center of NYU Langone. In his role, he specializes in treating thoracic cancers including lung cancer and malignant pleural mesothelioma. A recognized leader in lung cancer therapy, Dr. Chachoua became interested in the field of medicine, particularly in oncology, after
Dr. Andrea Wolf is a thoracic surgeon and Director of the New York Mesothelioma Program at the Mount Sinai Health System. She offers patients diagnosed with malignant pleural mesothelioma expertise in the treatment of her disease and skill in the use of a video-assisted thoracoscopic surgical procedure known as lobectomy. She is also skilled in
Dr. Kenneth Rosenzweig is a radiation oncologist at Mount Sinai Medical Center and a Professor and Chairman of the Department of Radiation Oncology at the Mount Sinai Icahn School of Medicine. He specializes in treating patients with malignant pleural mesothelioma, lung cancer, and other thoracic malignancies. His work in introducing new technology into radiation therapy
Dr. Charles A. Powell is the Chief of the Division of Pulmonary, Critical Care, and Sleep Medicine at the Icahn School of Medicine at Mount Sinai and an integral part of the facility’s lung cancer team. His clinical and research interests in malignant pleural mesothelioma make significant contributions to the multidisciplinary team’s approach to individual
Dr. Benjamin Herzberg is a medical oncologist practicing in New York City at the Herbert Irving Comprehensive Cancer Center. He specializes in treating thoracic malignancies, including malignant pleural mesothelioma, non-small cell lung cancer, small cell lung cancer, and thymoma. Dr. Herzberg is committed to providing compassionate, individualized care for his patients. His empathy is driven